NYSEFinancialsLife & Health InsuranceS&P MidCap 400
$290.58
+1.62 (+0.56%)
Close of Nov 06, 2026 · end-of-day data
PRI 8-K filings in 2026
Every material Form 8-K Primerica filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Primerica reported third-quarter 2026 results for the period ended September 30, 2026, with total revenues of $902 million, up 7% year over year, and net income of $209 million, up 1%. Diluted EPS of $6.76 rose 6%, and diluted adjusted operating EPS of $6.77 rose 7%, with the company also declaring a $1.20 per share dividend.
Total revenues of $902 million rose 7% from the third quarter of 2025
Investment and Savings Products sales rose 19% to $4.4 billion; Term Life adjusted operating income before income taxes fell 12%
Company returned $159 million to stockholders in the quarter, including $122 million of share repurchases
Board approved a $1.20 per share dividend payable December 14, 2026 to holders of record on November 20, 2026
Primerica reported second-quarter 2026 results, with total revenues of $865 million up 9% and net income of $202 million up 13% from a year earlier. Diluted EPS rose 19% to $6.45 and adjusted operating EPS rose 17% to $6.41. Term Life adjusted pre-tax income fell 4%, while the Investment and Savings Products segment's pre-tax income rose 31%.
Total revenues $865 million, up 9%; net income $202 million, up 13%
Diluted EPS $6.45, up 19%; diluted adjusted operating EPS $6.41, up 17%
Investment and Savings Products sales rose 23% to $4.4 billion; Term Life policies issued fell 12% to 78,904
Company repurchased $135 million of common stock and declared a $1.20 per share dividend payable September 14, 2026
On June 2, 2026, Primerica amended and restated its $200 million unsecured revolving credit facility, which was scheduled to expire on June 22, 2026. The amendment extends the maturity to June 2, 2031, modifies the Applicable Margin and adjusts certain financial covenants. No amounts were outstanding when the agreement was signed, and no amounts had been drawn as of the report date.
Facility size remains $200 million; maturity extended from June 22, 2026 to June 2, 2031
Lenders include The Bank of New York Mellon, Citibank, N.A., JP Morgan Chase Bank, N.A., Royal Bank of Canada, The Bank of Nova Scotia and Wells Fargo Bank, National Association
SOFR loan margins range from 1.00% to 1.625% per annum; commitment fee ranges from 0.08% to 0.225% of the unused portion, both set by the company's Debt Rating
No amounts have been drawn; proceeds may be used for general corporate purposes
Primerica reported first-quarter 2026 results on May 6, 2026, with total revenues of $872.7 million (up 8%) and net income of $190.1 million (up 12%). Diluted EPS of $5.97 rose 18%, and diluted adjusted operating EPS of $5.96 rose 19%, driven mainly by record Investment and Savings Products sales, while life-licensed recruiting and new term life policies declined.
Investment and Savings Products sales were a record $4.3 billion, up 22%, and average client asset values were $129.9 billion, up 15%.
Recruits fell 17% to 84,217, and the life-licensed sales force totaled 149,732 at March 31, 2026, down 2%.
Life insurance policies issued fell 14% to 74,054, and annualized issued term life premium decreased 10% to $83.3 million.
The company repurchased $135 million of common stock in the quarter and declared a $1.20 per share dividend payable June 12, 2026.
Primerica reported fourth quarter 2025 net income of $197.0 million, up 18% from continuing operations a year earlier, with diluted EPS of $6.13 versus $4.98. Total revenues rose 8% to $853.7 million, and the company also declared a 15% higher quarterly dividend of $1.20 per share and authorized a new $475 million share repurchase program through December 31, 2026.
Q4 2025 net income $197.0 million, up 18%; diluted EPS $6.13, up 23% from $4.98
Full-year 2025 net income $751.2 million, up 4%; diluted EPS $22.91, up 9%
Quarterly dividend raised 15% to $1.20 per share, payable March 13, 2026
New $475 million share repurchase program authorized through December 31, 2026
Primerica, Inc. said two longtime directors, Beatriz R. Perez and Gary L. Crittenden, will not stand for reelection at the annual stockholder meeting planned for May 2026. Both notified the board on January 19, 2026, and the company said their decisions are not due to any disagreement with the company, the board, management, or its operations, policies, or practices.
Beatriz R. Perez has served as a director for over 11 years and will not seek reelection.
Gary L. Crittenden has served as a director for over 12 years and will not seek reelection.
Both notified the board on January 19, 2026, ahead of the annual meeting of stockholders to be held in May 2026.
The filing states neither departure relates to any differences or disagreements with the company.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Primerica filing is on SEC EDGAR ↗. 8-K briefs of other companies →